Sign in
4

Changes in Ownership

WEST PHARMACEUTICAL SERVICES INC Filed Acc 0001127602-25-006135

Sr VP, Chief Financial Officer acquired 904.33 shares (option exercise)

  • Sr VP, Chief Financial Officer gave up 273.37 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Birkett Bernard Sr VP, Chief Financial Officer 2025-02-18 Option exercise +779.35 $211.00 $164,443 7,668.77 D
Birkett Bernard Sr VP, Chief Financial Officer 2025-02-18 Shares withheld for taxes −237.76 $211.00 $50,168 7,431.01 D
Birkett Bernard Sr VP, Chief Financial Officer 2025-02-18 Option exercise +124.98 $211.00 $26,370 7,555.99 D
Birkett Bernard Sr VP, Chief Financial Officer 2025-02-18 Shares withheld for taxes −35.61 $211.00 $7,513 7,520.38 D
Derivatives
Birkett Bernard Sr VP, Chief Financial Officer 2025-02-18 Grant or award · Stock Option (Right to Buy) +4,020 4,020 D
Birkett Bernard Sr VP, Chief Financial Officer 2025-02-18 Grant or award · Rst. Stock Unit +1,740 1,740 D
Loading xslF345X05/form4.xml…